A regulatory MDM4 genetic variant locating in the binding sequence of multiple MicroRNAs contributes to susceptibility of small cell lung cancer

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Gao, Feng ^a   Xiong, Xiangyu ^b   Pan, Wenting ^b   Yang, Xinyu ^b   Zhou, Changchun ^c   Yuan, Qipeng ^a   Zhou, Liqing ^d   Yang, Ming ^b  

^a Chinese PLA   (China)

^b BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

^c SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

^d Huaian No 2 Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MIR 191 5P; MIR 887 3P; PROTEIN MDMX; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MDM4 PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MDM4 GENE; NUCLEOTIDE BINDING SITE; RNA SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMALL CELL LUNG CANCER; SMOKING; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BINDING SITE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; LUNG TUMOR; METABOLISM; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

3' UNTRANSLATED REGIONS; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BINDING SITES; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS; SMALL CELL LUNG CARCINOMA; YOUNG ADULT;

EID: 84942923318     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0135647     Document Type: Article

References (35)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225-249. doi: 10.3322/caac.20006 PMID: 19474385
2. Jackman DM, Johnson BE. (2005) Small-cell lung cancer. Lancet 366:1385-1396. PMID: 16226617
3. Simon GR, Wagner H, American College of Chest Physicians (2003) Small cell lung cancer. Chest 23:259S-271S. PMID: 12527584
4. Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, Eisen T, et al. (2008)Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 40:616-22. doi: 10 038/ng.109 PMID: 18385676
5. Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, Zaridze D, et al. (2008) A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452:633-637. doi: 10.1038/nature06885 PMID: 18385738
6. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP, et al. (2008) A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452:638-642. doi: 10.1038/nature06846 PMID: 18385739
7. Wang Y, Broderick P, Webb E, Wu X, Vijayakrishnan J, Matakidou A, et al. (2008) Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet 40:1407-1409. doi: 10.1038/ng.273 PMID: 18978787
8. McKay JD, Hung RJ, Gaborieau V, Boffetta P, Chabrier A, Byrnes G, et al. (2008) Lung cancer susceptibility locus at 5p15.33. Nat Genet 40:1404-1406. doi: 10.1038/ng.254 PMID: 18978790
9. Wang Y, McKay JD, Rafnar T, Wang Z, Timofeeva MN, Broderick P, et al. (2014)Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet 46:736-741. doi: 10.1038/ng.3002 PMID: 24880342
10. Lan Q, Hsiung CA, Matsuo K, Hong YC, Seow A, Wang Z, et al.(2012) Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat Genet 44:1330-1335. doi: 10.1038/ng.2456 PMID: 23143601
11. Dong J, Hu Z, Wu C, Guo H, Zhou B, Lv J, et al. (2012) Association analyses identify multiple new lung cancer susceptibility loci and their interactions with smoking in the Chinese population. Nat Genet 44:895-899. doi: 10.1038/ng.2351 PMID: 22797725
12. Hu Z, Wu C, Shi Y, Guo H, Zhao X, Yin Z, et al. (2011) A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat Genet 43:792-796. doi: 10.1038/ng.875 PMID: 21725308
13. Shvarts A, Steegenga WT, Riteco N, van Laar T, Dekker P, Bazuine M, et al.(1996) MDMX: a novel p53-binding protein with some functional properties of MDM2. EMBO J 15:5349-5357. PMID: 8895579
14. Wade M, Wang YV, Wahl GM. (2010) The p53 orchestra: Mdm2 and Mdmx set the tone. Trends Cell Biol 20:299-309. doi: 10.1016/j.tcb.2010.01.009 PMID: 20172729
15. Kadakia M, Brown TL, McGorry MM, Berberich SJ. (2002) MdmX inhibits Smad transactivation. Oncogene 21:8776-8785. PMID: 12483531
16. Jin Y, Zeng SX, Sun XX, Lee H, Blattner C, Xiao Z, et al. (2008) MDMX promotes proteasomal turnover of p21 at G1 and early S phases independently of, but in cooperation with, MDM2. Mol Cell Biol 28:1218-1229. PMID: 18086887
17. Miller KR, Kelley K, Tuttle R, Berberich SJ. (2010) HdmX overexpression inhibits oncogene induced cellular senescence. Cell Cycle 9:3376-3382. doi: 10.4161/cc.9.16.12779 PMID: 20724842
18. Xiong S, Pant V, Suh YA, Van Pelt CS, Wang Y, Valentin-Vega YA, et al.(2010) Spontaneous tumorigenesis in mice overexpressing the p53-negative regulator Mdm4. Cancer Res 70:7148-7154. doi: 10 158/0008-5472.CAN-10-1457 PMID: 20736370
19. Wynendaele J, Böhnke A, Leucci E, Nielsen SJ, Lambertz I, Hammer S, et al. (2010) An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity. Cancer Res 70:9641-9649. doi: 10.1158/0008-5472.CAN-10-0527 PMID: 21084273
20. Stegeman S, Moya L, Selth LA, Spurdle AB, Clements J, Batra J. (2015) A genetic variant of MDM4 influences regulation by multiple microRNAs in prostate cancer. Endocr Relat Cancer 22:265-276. doi: 10.1530/ERC-15-02013 PMID: 25670033
21. McEvoy J, Ulyanov A, Brennan R, Wu G, Pounds S, Zhang J, et al. (2012) Analysis of MDM2 and MDM4 single nucleotide polymorphisms, mRNA splicing and protein expression in retinoblastoma. PLoS One 7:e42739. doi: 10.1371/journal.pone.0042739 PMID: 22916154
22. Zhou L, Zhang X, Li Z, Zhou C, Li M, Tang X, et al. (2013) Association of a genetic variation in a miR-191 binding site in MDM4 with risk of esophageal squamous cell carcinoma. PLoS One 8:e64331. doi: 10.1371/journal.pone.0064331 PMID: 23724042
23. Eeles RA, Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, et al. (2013) Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet 45:385-391. doi: 10.1038/ng.2560 PMID: 23535732
24. Garcia-Closas M, Couch FJ, Lindstrom S, Michailidou K, Schmidt MK, Brook MN, et al. (2013) Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet 45:392-498. doi: 10.1038/ng.2561 PMID: 23535733
25. Liu J, Tang X, Li M, Lu C, Shi J, Zhou L, et al. (2013) Functional MDM4 rs4245739 genetic variant, alone and in combination with P53 Arg72Pro polymorphism, contributes to breast cancer susceptibility. Breast Cancer Res Treat 140:151-157. doi: 10.1007/s10549-013-2615-x PMID: 23793604
26. Fan C, Wei J, Yuan C, Wang X, Jiang C, Zhou C, et al. (2014) The functional TP53 rs1042522 and MDM4 rs4245739 genetic variants contribute to Non-Hodgkin lymphoma risk. PLoS One 9:e107047. doi: 10.1371/journal.pone.0107047 PMID: 25203442
27. Zhang X, Zhou L, Fu G, Sun F, Shi J, Wei J, et al. (2014) The identification of an ESCC susceptibility SNP rs920778 that regulates the expression of lncRNA HOTAIR via a novel intronic enhancer. Carcinogenesis 35:2062-2067. doi: 10.1093/carcin/bgu103 PMID: 24788237
28. Zhang X, Wei J, Zhou L, Zhou C, Shi J, Yuan Q, et al. (2013) A functional BRCA1 coding sequence genetic variant contributes to risk of esophageal squamous cell carcinoma. Carcinogenesis 34:2309-2313. doi: 10.1093/carcin/bgt213 PMID: 23749772
29. Wang X, Li M, Wang Z, Han S, Tang X, Ge Y, et al. (2015) Silencing of Long Noncoding RNA MALAT1 by miR-101 and miR-217 Inhibits Proliferation, Migration, and Invasion of Esophageal Squamous Cell Carcinoma Cells. J Biol Chem 290:3925-3935. doi: 10.1074/jbc.M114.596866 PMID: 25538231
30. Wu C, Hu Z, Yu D, Huang L, Jin G, Liang J, et al. (2009) Genetic variants on chromosome 15q25 associated with lung cancer risk in Chinese populations. Cancer Res 69:5065-5072. doi: 10.1158/0008-5472.CAN-09-0081 PMID: 19491260
31. Shi J, Sun F, Peng L, Li B, Liu L, Zhou C, et al. (2013) Leukocyte telomere length-related genetic variants in 1p34.2 and 14q21 loci contribute to the risk of esophageal squamous cell carcinoma. Int J Cancer 132:2799-2807. doi: 10.1002/ijc.27959 PMID: 23180556
32. Yang M, Sun T, Zhou Y, Wang L, Liu L, Zhang X, et al. (2012) The functional cytotoxic T lymphocyteassociated Protein 4 49G-to-A genetic variant and risk of pancreatic cancer. Cancer 118:4681-4686. doi: 10.1002/cncr.27455 PMID: 22359319
33. Dally H, Edler L, Jäger B, Schmezer P, Spiegelhalder B, Dienemann H, et al. (2003) The CYP3A41B allele increases risk for small cell lung cancer: effect of gender and smoking dose. Pharmacogenetics 13:607-618. PMID: 14515059
34. Dally H, Gassner K, Jäger B, Schmezer P, Spiegelhalder B, Edler L, et al. (2002) Myeloperoxidase (MPO) genotype and lung cancer histologic types: the MPO-463 A allele is associated with reduced risk for small cell lung cancer in smokers. Int J Cancer 102:530-535. PMID: 12432558
35. Xiong F, Wu C, Chang J, Yu D, Xu B, Yuan P, et al. (2011) Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer. Cancer Res 71:5175-5181. doi: 10.1158/0008-5472.CAN-10-4407 PMID: 21676885